ZBIOZenas BioPharma, Inc.

$1B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-90.0% YoY

Gross Profit

-$134M-2682.8% margin

Operating Income

-$164M-3277.8% margin

Net Income

-$157M-3139.8% margin

EPS (Diluted)

$-3.76

Cash Flow

Operating Cash Flow

-$120M

Free Cash Flow

-$120M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$370M

Total Liabilities

$58M

Stockholders' Equity

$312M

Cash & Equivalents

$320M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$50M	-90.0%
Gross Profit	-$134M	$50M	-368.3%
Operating Income	-$164M	-$37M	-341.2%
Net Income	-$157M	-$37M	-322.9%

ZBIO FY 2024 Earnings — Zenas BioPharma, Inc. Revenue & Financial Results | Market Cap Arena